Abstract
Myelomatosis is strictly a neoplasm of plasma cells in bone marrow. It does not involve other sites of antibody production; thus, even when the monoclonal protein produced by the neoplastic clone is IgA1 or IgA2 the neoplastic cells are not found in the lamina propria of the gut (Leonard et al 1979). Importantly the production of an IgM paraprotein by the neoplastic cells is vanishingly rare, amounting to only 0.2 % of 2011 successive patients admitted to MRC myelomatosis trials. IgG paraproteins were found in 57.2 % (0.15% with IgG with a minor IgM paraprotien of the same light chain isotype), IgA in 27% (0.10% with IgA with a minor IgM paraprotein of the same light chain isotype), IgD in 1.5%, IgE 0.1%. Free light chains alone were produced by the neoplastic cells of 14% of patients and 1.8% had no paraprotein. Physiologically in the established phase of those T cell-dependent antibody responses where B cells are being activated in the spleen antibody production takes place in the bone marrow (Benner et al 1981). This also applies to responses in those lymph nodes which do not receive lymph from mucosal surfaces. It has been shown in rodents that the B cells are activated in the follicles of these secondary lymphoid tissues (Tew et al. 1992) and migrate via the lymph and/or blood to the marrow. Migrant plasmablasts can be found in the blood of healthy humans. Analysis of the life-span of bone marrow plasma cells in rats indicates that IgG-or IgA-secreting plasma cells survive for about a month (Ho et al 1986). Conversely the IgM-producing plasma cells in the marrow like most plasma cells in the spleen and lymph nodes, irrespective of the class of Immunoglobulin produced, live for only 3 days (Ho et al 1986). It may be that these IgM-producing cells have been generated by local activation of B cells at the surface of macrophages by T cell-independent antigens (Corbel and Melchers 1983). Normal human bone marrow does not contain obvious secondary lymphoid tissue so it seems likely that the IgG and IgA plasma cells in this tissue are also derived from distant secondary lymphoid tissues. (Studies of plasma cells from the bone marrow from patients with rheumatoid arthritis as a means for investigating the physiological equivalent of neoplastic cells in myelomatosis could be misleading; for the marrow in this disease contains well-developed secondary lymphoid tissue).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Askonas BA, Williamson AR and Wright BG (1970) Selection of a single antibody-forming clone and its propogation in syngeneic mice. Proc Natl Acad Sci. 67:1398.
Benner R, Hijmans W, Haaijman JJ (1981) The bone marrow: the major source of Immunoglobulins but still a neglected site of antibody formation. Clin Exp Immunol 46:1.
Blattner WA (1980) Epidemiology of multiple myeloma and related plasma cell disorders: An analytical review. In progress in myeloma Ed Potter M. Elsvier North Holland, New York 1.
Clynes R, Stanton LW, Wax J, Smith-Gill S, Potter M and Marcu KB (1988) Synergy of an IgH promotor-enhancer-driven c-myc/v-Ha-ras retrovirus and pristane in the induction of murine plasmacytomas. Curr Top Microbiol Immunol 141:115.
Corbel C and Melchers F (1983) Requirement for macrophages of T cell-derived factors in the mitogenic stimulation of murine B cells by LPS. Eur J Immunol 13:528.
Deves SS (1991) Descriptive Epidemiology of Multiple Myeloma. In Epidemiology and biology of multiple myeloma. Eds Obrams GI and Potter M, Springer-Verlag, Berlin, 3.
Epstein J and Hiroyuki H (1991) Multiple myeloma evolves from a malignant haemopoietic stem cell. In Epidemiology and biology of multiple myeloma. Eds Obrams GI and Potter M, Springer-Verlag, Berlin, 143.
Gray D, MacLennan ICM and Lane PJL (1986) Virgin B cell recruitment and the lifespan of memory B cell clones during antibody responses to DNP-hemocyanin. Eur J Immunol 16:641.
Gray D and Skarvall H (1988) B cell memory is short-lived in the absence of antigen. Nature 336:70.
Gu H, Tarlington D, Muller W, Rajewski K and Forster I (1991) Most peripheral B cells in mice are ligand selected. J Exp Med 173:1357.
Ho F, Lortan J, Khan M and MacLennan ICM (1986) Distinct short-lived and long-lived antibody-producing cell populations. Eur J Immunol 16:1297.
Kubagawa H, Vogler LB, Cappra JE, Conrad E, Lawton AR and Cooper MD (1979) Studies of the clonal origin of multiple Myeloma. J. Exp. Med. 150:792.
Leonard RFL, MacLennan ICM, Sart Y, Vanhegan RI and Cuzick J (1979) Light chain isotype-associated suppression of normal plasma cell numbers in patients with myelomatosis. Internat J Cancer 24:385.
Liu Y-J, Oldfield S and MacLennan ICM (1988) Memory B cells in T cell-dependent antibody responses colonize the splenic marginal zones. Eur J Immunol 18:355.
Liu Y-J, Zhang J, Lane PJL, Chan E Y-T and MacLennan ICM (1991) Sites of specific B cell activation in primary and secondary responses to T cell-dependent and T cellindependent antigens. Eur J Immunol 21:2951.
MacLennan ICM and Gray D (1986) Antigen-driven selection of virgin and memory B cells. Immunol Rev 91:61.
MacLennan ICM, Liu Y-J, Oldfield S, Zhang J and Lane PJL (1990) The evolution of B cell clones. Curr Top Microbiol Immunol 159:37.
MacLennan ICM, Liu Y-J and Johnson GD (1992) Maturation and dispersal of B cell clones during T cell-dependent antibody responses. Immunol Rev 126:143.
Tew JG, DiLosa R M, Burton GF, Kosco M, Kupp LI, Masuda A and Szakal AK (1992) Germinal centres and antibody production in bone marrow. Immunol Rev 126:99.
Warburton P, Joshua DE, Gibson J and Brown RD (1989) CD10-(CALLA)-positive lymphocytes in myeloma: evidence that they are a malignant precursor population and are of germinal centre origin. Leuk Lym 1, 1.
Wiltshaw E (1976) The natural history of extra medullary plasmacytoma and its relation to solitory plasmacytoma of bone and myelomatosis. Medicine 55:217.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
MacLennan, I.C.M. (1992). In Which Cells Does Neoplastic Transformation Occur in Myelomatosis?. In: Potter, M., Melchers, F. (eds) Mechanisms in B-Cell Neoplasia 1992. Current Topics in Microbiology and Immunology, vol 182. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77633-5_25
Download citation
DOI: https://doi.org/10.1007/978-3-642-77633-5_25
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-77635-9
Online ISBN: 978-3-642-77633-5
eBook Packages: Springer Book Archive